-
Apixaban, sold
under the
brand name Eliquis, is an
anticoagulant medication used to
treat and
prevent blood clots and to
prevent stroke in
people with...
- risk factors. For example, in a
study examining the
effect of the drug
apixaban on the
occurrence of thromboembolism, 8.8% of placebo-treated patients...
-
commercially available in
Europe and
Canada in 2008. The
second one was
apixaban (Eliquis),
approved in
Europe in 2011 and in the
United States in 2012...
-
mortality when
compared to
other anticoagulants like
apixaban, edoxaban, and rivaroxaban. Notably,
apixaban was ****ociated with a
lower risk of gastrointestinal...
- are the Pfizer–BioNTech COVID-19
vaccine ($11
billion in 2023 revenues),
apixaban ($6
billion in 2023 revenues), a
pneumococcal conjugate vaccine ($6 billion...
-
Andexxa among others, is an
antidote for the
medications rivaroxaban and
apixaban, when
reversal of
anticoagulation is
needed due to
uncontrolled bleeding...
-
antagonists by
American professional guidelines. Two of
these (rivaroxaban and
apixaban) do not
require initial heparin or
fondaparinux treatment,
whereas dabigatran...
-
thinners is the
standard treatment.
Typical medications include rivaroxaban,
apixaban, and warfarin.
Beginning warfarin treatment requires an
additional non-oral...
- po****tion and
minor bleeding in 167 more
people per 1000 po****tion.
Apixaban had no
effect on mortality,
recurrence of
blood clots in
blood vessels...
-
anticoagulant drugs (DOACs, e.g. dabigatran, rivaroxaban, edoxaban, or
apixaban) is recommended. If the
patient is 'low risk'
using the CHA2DS2-VASc score...
